he US Food and Drug Administration (FDA) has granted 510(k) clearance to Providence Medical Technology for its CORUS Posterior Cervical Stabilization System 3D-T.
The device is indicated to stabilise and immobilise spinal segments alongside posterior cervical fusion in patients with cervical degenerative disc disease.
Manufactured with a 3D porous titanium structure, the bilateral implant incorporates integrated screw fixation as a nonsegmental posterior instrumentation tool.